vaccine adjuvant monophosphoryl lipid trif-biased agonist tlr4 
inflammatory toxicity lipopolysaccharide lps component bacterial cell walls driven adaptor proteins myeloid differentiation factor myd88 toll-interleukin receptor domain-containing adapter inducing interferon-beta trif together mediate signaling endotoxin receptor toll-like receptor tlr4 monophosphoryl lipid mpla low-toxicity derivative lps useful immunostimulatory properties nearing regulatory approval use human vaccine adjuvant report mice low toxicity mplas adjuvant function associated bias toward trif signaling suggest likely caused active suppression rather passive loss proinflammatory activity lps derivative finding may important implications development future vaccine adjuvants 
